Atlantic Melanoma Center

Morristown, New Jersey 07962

0 studies enrolling now · 7 studies all time

What they study most

COVID, COVID-19, COVID19, High Risk Stage III Melanoma, Malignant Melanoma, Melanoma, Metastatic (Stage IV) Melanoma, Unresectable (Stage III) Melanoma

Studies at this site

• Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma — Completed
• RTA 408 Capsules in Patients With Melanoma - REVEAL — Completed
• PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer — Stopped early
• Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) — Completed
• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed
• A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ) — Completed